Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

This research highlights the indirect role of fructose in cancer, revealing how liver metabolism enhances tumor growth ...

The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of ...